Advertisement
Original research| Volume 100, ISSUE 2, P300-306.e1, February 2019

Download started.

Ok

Immediate Effects of Transcutaneous Electrical Nerve Stimulation on Pain and Physical Performance in Individuals With Preradiographic Knee Osteoarthritis: A Randomized Controlled Trial

Open AccessPublished:October 10, 2018DOI:https://doi.org/10.1016/j.apmr.2018.08.189

      Abstract

      Objective

      To investigate the effect of transcutaneous electrical nerve stimulation (TENS) on knee pain and comprehensive physical function in preradiographic knee osteoarthritis.

      Design

      A single, participant-blinded, randomized controlled trial (RCT) with pre-post design.

      Setting

      University research laboratory.

      Participants

      Patients with knee pain belonging to Kellgren–Lawrence grade 0 or 1 (N=50; aged 50-69y) were randomly assigned to the TENS (n=25) and sham-TENS groups (n=25).

      Interventions

      All participants wore the TENS device under the patella of the symptomatic knee. After measurement, the TENS devices in the TENS group were turned on, and those in the sham-TENS group were not connected.

      Main Outcome Measures

      The primary outcome measures included the stair climb test, timed Up and Go (TUG) test, 6-minute walk test (6MWT), and knee pain evaluated using the visual analog scale (VAS) for stair climb test, TUG test, and 6MWT. Secondary outcomes included knee extensor strengths and the 2-step test and stand-up test from the locomotive syndrome risk test.

      Results

      Multiple regression analysis revealed that TENS intervention significantly improved the walk distance and VAS score of the 6MWT, after adjusting for premeasurement data (distance; P=.015, VAS; P=.030).

      Conclusions

      Use of TENS improved the VAS score for pain and the distance walked in the 6MWT for individuals with Kellgren–Lawrence grade 0 or 1 of the knee. Thus, TENS may be effective for long-distance walking in patients with preradiographic knee osteoarthritis.

      Keywords

      List of abbreviations:

      CI (confidence interval), HHD (handheld dynamometer), JKOM (Japanese Knee Osteoarthritis Measure), JOA (Japanese Orthopaedic Association), K/L (Kellgren–Lawrence), MDC (minimal detectable change), OA (osteoarthritis), OARSI (Osteoarthritis Research Society International), RCT (randomized controlled trial), TENS (transcutaneous electrical nerve stimulation), TUG (timed Up and Go), VAS (visual analog scale), WOMAC (Western Ontario and McMaster Universities Arthritis Index scale), 6MWT (6-minute walk test)
      Knee osteoarthritis (OA), which causes knee joint pain, stiffness, and functional disability,
      • Richmond J.
      • Hunter D.
      • Irrgang J.
      • et al.
      Treatment of osteoarthritis of the knee (nonarthroplasty).
      is common among elderly individuals worldwide.
      • Woolf A.D.
      • Pfleger B.
      Burden of major musculoskeletal conditions.
      A previous study reported that 27.8% of individuals aged 45 years or older had a prevalence of radiographic knee OA (Kellgren–Lawrence [K/L] grade of at least 2 in at least 1 knee) and 43.3% had a symptomatic knee (pain, aching, or stiffness in at least 1 knee).
      • Jordan J.M.
      • Helmick C.G.
      • Renner J.B.
      • et al.
      Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project.
      To date, no useful treatment or preventive measures for knee OA are available; thus, pain management is the main therapy.
      Transcutaneous electrical nerve stimulation (TENS) is a commonly used conservative treatment method that is effective in alleviating the pain in knee OA.
      • Chen W.L.
      • Hsu W.C.
      • Lin Y.J.
      • Hsieh L.F.
      Comparison of intra-articular hyaluronic acid injections with transcutaneous electric nerve stimulation for the management of knee osteoarthritis: a randomized controlled trial.
      • Cherian J.J.
      • Kapadia B.H.
      • McElroy M.J.
      • et al.
      Knee osteoarthritis: does transcutaneous electrical nerve stimulation work?.
      • Chen L.-X.
      • Zhou Z.-R.
      • Li Y.-L.
      • et al.
      Transcutaneous electrical nerve stimulation in patients with knee osteoarthritis.
      However, some randomized controlled trials (RCTs) or systematic reviews found no significant differences in knee pain between patients who received TENS, and the sham group.
      • Atamaz F.C.
      • Durmaz B.
      • Baydar M.
      • et al.
      Comparison of the efficacy of transcutaneous electrical nerve stimulation, interferential currents, and shortwave diathermy in knee osteoarthritis: a double-blind, randomized, controlled, multicenter study.
      • Palmer S.
      • Domaille M.
      • Cramp F.
      • et al.
      Transcutaneous electrical nerve stimulation as an adjunct to education and exercise for knee osteoarthritis: a randomized controlled trial.
      • Zeng C.
      • Li H.
      • Yang T.
      • et al.
      Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis.
      Thus, whether TENS is effective for knee OA remains unclear. Moreover, the main outcome of these previous studies on TENS is knee pain, which was measured using instruments such as the visual analog scale (VAS) or Western Ontario and McMaster Universities Arthritis Index scale (WOMAC). Decrease in pain can improve physical function; however, limited studies have exhaustively measured the effect of decrease in pain on physical function through factors such as muscle strength, speed, endurance, and balance. Further, few studies have revealed the effect of TENS intervention during physical functional tests.
      We focused on the locomotive syndrome risk test as an exhaustive physical function test. In 2007, the Japanese Orthopaedic Association (JOA) proposed the term locomotive syndrome, which refers to a decline in locomotive ability caused by diseases of the bones, joints, muscles, and nerves.
      • Nakamura K.
      A “super-aged” society and the “locomotive syndrome.”.
      In 2013, the JOA proposed the locomotive syndrome risk test, which includes the 2-step test, stand-up test, and 25-question risk assessment.

      Japanese Orthopaedic Association. Locomotive syndrome. In: Locomotive Challenge! Council, editors. Locomotive syndrome pamphlet 2013.

      Knee OA is one of the diseases that causes locomotive syndrome; thus, the locomotive syndrome risk test can be an important measure of functional ability.
      Several studies on knee OA have revealed discordance between radiographic evaluation and the somatic symptoms of this condition. The K/L grade is a common radiographic evaluation system for knee OA; it involves classification of knee OA according to the severity of bone deformity.
      • Kellgren J.H.
      • Lawrence J.S.
      Radiological assessment of osteo-arthrosis.
      However, no significant association has been found between K/L grade and knee pain,
      • Felson D.T.
      • Zhang Y.
      • Hannan M.T.
      • et al.
      The incidence and natural history of knee ostoathritis in the elderly. The Framingham Osteoarthritis Study.
      leg extensor and flexor muscle strengths, and WOMAC.
      • Tuna S.
      • Balci N.
      The relationship between radiological severity and functional status in patients with knee osteoarthritis.
      • Ruhdorfer A.
      • Wirth W.
      • Hitzl W.
      • Nevitt M.
      • Eckstein F.
      Association of thigh muscle strength with knee symptoms and radiographic disease stage of osteoarthritis: data from the osteoarthritis initiative.
      Moreover, individuals whose K/L score is 0 may have cartilage damage or bone marrow lesions, as demonstrated using magnetic resonance imaging.
      • Guermazi A.
      • Niu J.
      • Hayashi D.
      • et al.
      Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).
      Thus, even individuals with K/L grade 0 or 1 (preradiographic OA) may have knee pain or inadequate function. Additionally, individuals with preradiographic OA, particularly with K/L grade 1, have been predicted to progress to at least grade 2.
      • Hart D.J.
      • Spector T.D.
      Kellgren & Lawrence grade 1 osteophytes in the knee--doubtful or definite?.
      • Cibere J.
      • Sayre E.C.
      • Guermazi A.
      • et al.
      Natural history of cartilage damage and osteoarthritis progression on magnetic resonance imaging in a population-based cohort with knee pain.
      Moreover, individuals with early-stage knee OA are likely to show better response to treatment than patients with more advanced osteoarthritis do.
      • Bruyere O.
      • Cooper C.
      • Arden N.
      • et al.
      Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.
      Thus, to prevent the progression of knee OA or to avoid the functional disability associated with it, preradiographic OA is an important stage for intervention or treatment. However, studies on the treatment of or physical function in preradiographic OA are lacking. Most studies on TENS for knee OA have investigated only patients with K/L grade ≥2; no study in individuals with preradiographic OA has been conducted. Therefore, this study aimed to investigate the effect of TENS on comprehensive physical function and knee pain during physical functional tests for individuals with preradiographic OA. In addition, we sought to examine the hypothesis that TENS reduces knee pain during physical function tests in individuals with preradiographic OA and improves the physical function of individuals with preradiographic OA, thus reducing knee pain.

      Methods

      Study design

      This was a single, participant-blinded, RCT with a prepost design, in which 2 parallel groups were compared, namely the TENS group and the control (sham-TENS) group. The study protocol was approved by the institutional review board. Written informed consent was obtained from all participants before enrollment.

      Participants

      Information regarding this study was posted on a website, and interested individuals answered a questionnaire concerning their physical condition. Whether the participants met the selection criteria was assessed via the questionnaire responses (supplemental appendix S1, available online only at http://www.archives-pmr.org/).

      Assessments

      All outcome measure assessments and radiographic studies were performed at baseline. After a 30-minute rest, participants were re-evaluated while wearing the TENS device. The primary outcome measures included the stair climb test, timed Up and Go (TUG) test, 6-minute walk test (6MWT), and knee pain evaluated using the VAS for the stair climb test, TUG test, and 6-minute walk test. The secondary outcomes include knee extensor strengths and the 2-step test and the stand-up test in the locomotive syndrome risk test.
      The stair climb test, TUG test, and 6MWT were conducted according to OARSI-recommended performance-based tests.
      • Dobson F.
      • Hinman R.S.
      • Roos E.M.
      • et al.
      OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis.
      The 2-step test and the stand-up test were performed according to the locomotive syndrome risk tests proposed by the JOA.

      Japanese Orthopaedic Association. Locomotive syndrome. In: Locomotive Challenge! Council, editors. Locomotive syndrome pamphlet 2013.

      Knee pain and disability characteristics at baseline were evaluated using a subcategory of the Japanese Knee Osteoarthritis Measure (JKOM).

      Demographic data

      Data on height, weight, age, and sex were reported by the participants themselves. Body mass index was calculated by dividing the weight by the square of the height.

      Radiographic evaluation

      Anteroposterior radiography of the index knees was performed in fully extended weight-bearing and foot map positions. The beam was positioned parallel to the floor. The radiographs were assessed by an experienced physician with more than 10 years of clinical experience, using the original version of the K/L classification system.
      • Kellgren J.H.
      • Lawrence J.S.
      Radiological assessment of osteo-arthrosis.
      We previously reported excellent intra-rater and inter-rater agreements for K/L grade determination (intra-rater, κ: 0.90).
      • Iijima H.
      • Fukutani N.
      • Aoyama T.
      • et al.
      Clinical impact of coexisting patellofemoral osteoarthritis in Japanese patients with medial knee osteoarthritis.

      Stair climb test

      An 11-step stairway with a step height of 17 cm was used. Participants began with both feet on the bottom landing, then ascended and descended the stairway as fast as possible, and finally stopped with both feet back on the bottom landing while availing handrail support, if required. Time recording was started when the participant was signaled to start and ended when the participant returned with both feet on the ground. The total time was recorded to the nearest one hundredth of a second. Two trials were performed, and the faster time of the 2 trials was recorded. The minimal detectable change (MDC) with 95% confidence interval (CI) was 2.77 seconds.
      • Dobson F.
      • Hinman R.S.
      • Hall M.
      • et al.
      Reliability and measurement error of the Osteoarthritis Research Society International (OARSI) recommended performance-based tests of physical function in people with hip and knee osteoarthritis.

      TUG test

      In this test, the participant sat down at first and then stood up when given the signal to start. As fast as possible, the participant walked 3 meters toward a cone on the floor, circled it, walked back 3 more meters toward a chair, and finally sat down. Timing began on the signal to start and ended when the participant completely sat down with their back resting on the backrest of the chair. Two trials were performed, and the faster time of the 2 trials was recorded to the nearest one hundredth of a second. The MDC with 95% CI was 1.39 seconds.
      • Dobson F.
      • Hinman R.S.
      • Hall M.
      • et al.
      Reliability and measurement error of the Osteoarthritis Research Society International (OARSI) recommended performance-based tests of physical function in people with hip and knee osteoarthritis.

      6MWT

      In the 6MWT, the participants walked as far as they could within 6 minutes. They were not allowed to carry a watch or provided feedback during the trial. Although rest periods were allowed, time recording continued. The participants were provided encouragement at 1-minute intervals. Their performance was measured as the total distance traveled, and was recorded as an integral number. The MDC with 95% CI was 50.23 m.
      • Dobson F.
      • Hinman R.S.
      • Hall M.
      • et al.
      Reliability and measurement error of the Osteoarthritis Research Society International (OARSI) recommended performance-based tests of physical function in people with hip and knee osteoarthritis.

      Knee extensor strengths

      The maximum isometric knee extensor strengths were measured using a handheld dynamometer (HHD), which is the validated method in a previous research on elderly individuals who are prone to falls.
      • Wang C.Y.
      • Olson S.L.
      • Protas E.J.
      Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers.
      The maximum force was recorded in Newtons (N), and testing was repeated for 2 measurements. The measurements were started once the participants were seated on the therapy bed. The knee was placed at 90° flexion, with the HHD being attached 10 cm proximal to the lateral malleolus and held in place with an inelastic strap looped around the therapy bed and fastened. The length of the straps allowed for an isometric contraction to be performed, with the knee at 90° flexion. The participants were instructed to extend their leg for 5 seconds. Strong verbal encouragement was provided to ensure maximal effort. To provide moment value (Nm), the lever arm (length of the femur or tibia) between the knee joint and HHD was manually measured and subsequently normalized to their mass (Nm/kg). The averaged value of 2 measurements was used for statistical analysis.

      Locomotive syndrome risk test

      The locomotive syndrome risk test includes the 2-step test, stand-up test, and 25-question risk assessment. Each test detects locomotive syndrome stages 1 (the beginning of decreased locomotive ability) and 2 (progression of decreased locomotive ability), and participants who fulfill the criteria for a test are classified accordingly as stage 1 or 2. In this study, the 2-step test and stand-up test were selected as the comprehensive physical function tests.

      Locomotive syndrome risk test: 2-step test

      Here, stride length is measured to assess walking ability, including muscle strength, balance, and flexibility of the lower limbs. The starting line is determined, and participants stand with the toes of both feet behind this line. They take 2 long steps (as long as possible) and then align both their feet. Subsequently, the length of the 2 steps from the starting line to the toes is measured. Two trials were performed in this study, and the longer distance of the 2 trials was recorded. The 2-step test score was calculated as follows: length of the 2 steps (cm)/participant height (cm). Locomotive syndrome stage 1 was defined as a score <1.3, and stage 2 was defined as a score <1.1.

      Locomotive syndrome risk test: stand-up test

      This test requires the participant to stand up on 1 or both legs from a seat at a specified height. For this test, 4 seats are set up at different heights (40, 30, 20, and 10 cm). First, the participants sit on the 40-cm high seat with arms folded. If they can stand up on both legs, they then attempt to stand on 1 leg. If they can stand up on both their right and left legs, they pass the height level. The participants then repeat the trial at the next seat height, and the trials are performed in the order of descending height. Locomotive syndrome stage 1 is defined as the inability to stand up from a height of 40 cm on either leg, and stage 2, as the inability to stand up from a height of 20 cm on both legs.

      VAS score for knee pain

      The mean knee pain during the stair climb test, TUG test, and 6MWT was measured using the VAS.
      • Katz J.
      • Melzack R.
      Measurement of pain.
      Participants recorded their level of knee pain by drawing a vertical mark between the ends of a 10-cm horizontal line. The 0-cm end and the 10-cm end represented no pain and the most extreme pain, respectively. The distance from the 0-cm end to the drawn mark was recorded to the first decimal place. The MDC with 95% CI was 2.8 cm.
      • Naylor J.M.
      • Hayen A.
      • Davidson E.
      • et al.
      Minimal detectable change for mobility and patient-reported tools in people with osteoarthritis awaiting arthroplasty.

      JKOM

      The JKOM
      • Akai M.
      • Doi T.
      • Fujino K.
      • Iwaya T.
      • Kurosawa H.
      • Nasu T.
      An outcome measure for Japanese people with knee osteoarthritis.
      was used to evaluate baseline knee pain and disability. The JKOM is a self-reported evaluation system comprising 25 questions and a VAS score for current knee pain. It assesses pain and stiffness, activities of daily living, participation in social activities, and general health conditions. Each question is scored on a 4-point scale, and the maximum possible score is 100 points in a person-specific assessment. The concurrent and construct validities of the JKOM have been established against the WOMAC and the Medical Outcomes Study 36-item Short-Form Health Survey, respectively.
      • Akai M.
      • Doi T.
      • Fujino K.
      • Iwaya T.
      • Kurosawa H.
      • Nasu T.
      An outcome measure for Japanese people with knee osteoarthritis.

      Treatment procedures

      After baseline assessment, all participants wore the TENS devicea under the patella of the symptomatic knee, with the knee flexed at 90°. The following TENS parameters were applied: sweep mode from 1 to 250 Hz, symmetrical biphasic pulse, and a pulse width of 60 μs.
      • Tokuda M.
      • Tabira K.
      • Masuda T.
      • Nishiwada T.
      • Shomoto K.
      Effect of modulated-frequency and modulated-intensity transcutaneous electrical nerve stimulation after abdominal surgery: a randomized controlled trial.
      The intensity in the TENS group was gradually increased and limited by the participant’s perception of a strong but comfortable, nonpainful tingle immediately below the visible motor threshold. The intensity was gradually increased during the intervention, as sensation decreases owing to habituation.
      • Aarskog R.
      • Johnson M.I.
      • Demmink J.H.
      • et al.
      Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo-controlled trial in healthy subjects.
      For participants in the sham-TENS group, sham stimulation of gradually increasing intensity of a nonconnected channel was applied, and participants were informed that owing to the expected effect being below the sensory threshold, they would not perceive any currents. The postassessment measurements were then carried out with the participants wearing the TENS device. All interventions were performed by physical therapists with clinical experience in musculoskeletal medicine.

      Statistical analyses

      Student’s t test or chi-square test was used to assess for significant baseline differences in characteristics between the TENS and sham-TENS groups. The Shapiro–Wilk test was used to confirm the statistical normality of outcome variables. To identify within-group differences, paired samples t tests or Wilcoxon signed rank test for continuous variables and chi-square test for categorical variables were used. Baseline-adjusted multiple regression analysis models were used to evaluate between-group differences for outcomes that had significant within-group differences.
      P<.05 was considered statistically significant, and all data were analyzed using the JMP Pro 13.0.0b (SAS Institute, Cary, NC).

      Results

      In total, 59 participants were evaluated, 9 of whom (16.9%) were excluded because of mild radiographic OA (K/L grade=2). Thus, 50 participants (n=25 in each group) were finally included (fig 1).
      Table 1 shows the baseline characteristics of the 50 participants. No difference was observed in the baseline characteristics between the groups (supplemental table S1 [available online only at http://www.archives-pmr.org/]).
      Table 1Physical characteristics of TENS and sham TENS group subjects
      CharacteristicTENS (n=25)Sham (n=25)P
      Height, cm161.0±7.53160.1±8.38.70
      Weight, kg55.9±7.9458.4±12.06.40
      BMI, kg/m221.6±2.6222.6±3.46.23
      Age, y59.1±6.1357.9±5.07.45
      Women, n (%)19 (76.0)16 (64.0).35
      K/L grade 0, n (%)11 (44.0)12 (48.0).78
      K/L grade 1, n (%)14 (56.0)13 (52.0)
      JKOM15.6±8.8512.5±6.78.17
      Baseline NRS5.40±1.155.16±1.31.50
      NOTE. Continuous data are expressed as mean ± SD (Student t test). Categorical data are expressed as n (%) (chi-square test).
      Abbreviation: NRS, numeric rating scale.
      Table 2 shows the results of each outcome within the groups using paired samples t tests, Wilcoxon signed rank test or chi-square test.
      Table 2Wilcoxon signed rank test and paired t test
      VariablePrePostP
      Stair climb test, s
       TENS
      Wilcoxon signed rank test.
      9.21±1.368.80±1.23.001
      Significant difference (P<.01).
       Sham TENS
      Wilcoxon signed rank test.
      8.48±1.378.43±1.36.154
      VAS of stair climb test, cm
       TENS
      Wilcoxon signed rank test.
      1.44±1.550.77±1.40.006
      Significant difference (P<.01).
       Sham TENS
      Wilcoxon signed rank test.
      1.78±1.991.15±1.46.016
      Significant difference (P<.05).
      TUG, s
       TENS
      Paired t test.
      5.95±0.625.59±0.47.001
      Significant difference (P<.05).
       Sham TENS
      Wilcoxon signed rank test.
      5.79±0.705.42±0.44.001
      Significant difference (P<.05).
      VAS of TUG, cm
       TENS
      Wilcoxon signed rank test.
      0.90±1.270.52±0.96.019
      Significant difference (P<.05).
       Sham TENS
      Wilcoxon signed rank test.
      0.89±1.040.70±0.86.245
      6MWT, m
       TENS
      Paired t test.
      501.6±41.4522.0±34.6.021
      Significant difference (P<.05).
       Sham TENS
      Paired t test.
      554.8±49.6571.4±40.8.072
      VAS of 6MWT, cm
       TENS
      Wilcoxon signed rank test.
      1.57±1.670.51±0.80.001
      Significant difference (P<.01).
       Sham TENS
      Wilcoxon signed rank test.
      1.89±2.081.14±1.09.049
      Significant difference (P<.05).
      Strength of knee extension, N·m/kg
       TENS
      Wilcoxon signed rank test.
      1.41±0.551.48±0.57.117
       Sham TENS
      Wilcoxon signed rank test.
      1.45±0.411.59±0.44.077
      Chi-squared TestPrePostP
      Stand-up test
       TENS.6868
      011 (44.0)14 (56.0)
      113 (52.0)10 (40.0)
      21 (4.0)1 (4.0)
       Sham TENS.5866
      017 (68.0)17 (68.0)
      18 (32.0)7 (28.0)
      20 (0.0)1 (2.0)
      2-step test
       TENS1.00
      016 (64.0)16 (64.0)
      19 (36.0)9 (36.0)
      20 (0.0)0 (0.0)
       Sham TENS.2971
      024 (96.0)22 (88.0)
      11 (4.0)3 (12.0)
      20 (0.0)0 (0.0)
      NOTE. Data are presented as means ± SD or n (%) or as otherwise indicated.
      Wilcoxon signed rank test.
      Paired t test.
      Significant difference (P<.05).
      § Significant difference (P<.01).
      Table 3 shows the results of each outcome between the groups, adjusted for premeasurement data as baseline. Multiple regression analysis revealed that compared to sham-TENS, TENS intervention significantly improved the walk distance and VAS score of the 6MWT, after adjusting for premeasurement data.
      Table 3Multiple regression analysis
      Dependent VariableBSEβP
      Post stair climb test time
       TENS intervention0.1200.0900.090.200
       Pre stair climb test time0.8410.0650.906.001
      Significant difference (P<.01).
      Post VAS of stair climb test
       TENS intervention0.0880.1410.062.537
       Pre VAS of stair climb test0.5830.0800.724.001
      Significant difference (P<.01).
      Post TUG time
       TENS intervention-0.0440.045-0.098.336
       Pre TUG time0.4940.0700.712.001
      Significant difference (P<.01).
      Post VAS of TUG
       TENS intervention0.0980.0930.109.297
       Pre VAS of TUG0.5440.0820.691.001
      Significant difference (P<.01).
      Post 6MWT distance
       TENS intervention13.9155.4850.313.015
      Significant difference (P<.05).
       Pre 6MWT distance0.4050.1050.474.001
      Significant difference (P<.01).
      Post VAS of 6MWT
       TENS intervention0.2730.1180.276.026
      Significant difference (P<.05).
       Pre VAS of 6MWT0.2540.0640.476.001
      Significant difference (P<.01).
      Post strength of knee extension
       TENS intervention0.0430.0500.085.395
       Pre strength of knee extension0.7680.1050.725.001
      Significant difference (P<.01).
      Significant difference (P<.05).
      Significant difference (P<.01).
      No adverse effect was noted with the TENS or sham-TENS treatment.

      Discussion

      The most important finding of the present study was that a significantly immediate effect of TENS was observed in terms of improvement in the walk distance and VAS score of 6MWT in participants with preradiographic knee OA.
      TENS is effective for nociceptive pain mechanisms based on the gate control theory of pain
      • Melzack R.
      • Wall P.D.
      Pain mechanisms: a new theory.
      and activation of endogenous opioids,
      • Sluka K.A.
      • Walsh D.
      Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness.
      and it may improve exercise tolerance in individuals who experience movement-evoked pain.
      • Chimenti R.L.
      • Frey-Law L.A.
      • Sluka K.A.
      A mechanism-based approach to physical therapist management of pain.
      In this study, TENS intervention was considered to reduce knee movement-evoked pain and increase walking distance. Thus, participants in the TENS group may be able to walk longer distances in the postassessment period. In addition, compared to TUG or timed-stand test, the 6MWT was shown to be more responsive after physiotherapy in patients with knee OA.
      • French H.P.
      • Fitzpatrick M.
      • Fitzgerald O.
      Responsiveness of physical function outcomes following physiotherapy intervention for osteoarthritis of the knee: an outcome comparison study.
      The 6MWT takes a longer time and is a high-intensity test; thus, participants may tend to experience knee pain. In this study, the VAS score of 6MWT was higher than that of any other physical task, which may influence the performance in 6MWT. This result is consistent with a previous finding that whole body vibration exercise for patients with knee OA significantly improved the score of 6MWT; however, no significant change was noted in the TUG score.
      • Wang P.
      • Yang L.
      • Liu C.
      • et al.
      Effects of whole body vibration exercise associated with quadriceps resistance exercise on functioning and quality of life in patients with knee osteoarthritis: a randomized controlled trial.
      A previous study reported that the minimal clinically important difference of VAS score is 1.1 point in patients who have a VAS pain of 3.0 cm or lower.
      • Kelly A.M.
      The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain.
      Thus, decrease in the VAS pain after intervention in the TENS group was nearly equal to the minimal clinically important difference; however, the difference in the sham-TENS group did not reach this level. If the minimal clinically important difference is considered as a standard, this result would be clinically meaningful.
      No significant difference was observed in the stair climb test, TUG, and knee extensor strengths between the groups. Patients with knee OA tend to experience knee pain while using the stairs owing to weight-bearing and knee bending.
      • Hensor E.M.
      • Dube B.
      • Kingsbury S.R.
      • Tennant A.
      • Conaghan P.G.
      Toward a clinical definition of early osteoarthritis: onset of patient-reported knee pain begins on stairs. Data from the osteoarthritis initiative.
      Thus, stair climb test was selected for the outcome of this study, as it was considered sufficiently difficult for participants with preradiographic knee OA. However, participants felt mild pain during the stair climb test or TUG test, with a VAS score <2. Stair climb test and TUG test are shorter-duration tests than 6MWT is, and they mainly assess speed agility; thus, mild pain that reflects a VAS score <2 may carry little significance for the 2 tests. This result supports a previous finding that no significant effect was observed in the use of TENS in the stair climb test or TUG for patients with knee OA.
      • Cherian J.J.
      • Kapadia B.H.
      • McElroy M.J.
      • et al.
      Knee osteoarthritis: does transcutaneous electrical nerve stimulation work?.
      Knee extensor strength is also a momentary measurement, and several previous studies have shown similar results.
      • Palmer S.
      • Domaille M.
      • Cramp F.
      • et al.
      Transcutaneous electrical nerve stimulation as an adjunct to education and exercise for knee osteoarthritis: a randomized controlled trial.
      • Cheing G.L.
      • Hui-Chan C.W.
      Would the addition of TENS to exercise training produce better physical performance outcomes in people with knee osteoarthritis than either intervention alone?.
      As per OARSI guidelines, the recommendation of TENS is uncertain; no optimal size has been reported owing to the low methodological quality and high heterogeneity among the included trials.
      • McAlindon T.E.
      • Bannuru R.R.
      • Sullivan M.C.
      • et al.
      OARSI guidelines for the non-surgical management of knee osteoarthritis.
      Additionally, several RCTs revealed no statistically significant difference in knee pain between participants undergoing the TENS and a sham-TENS procedure.
      • Atamaz F.C.
      • Durmaz B.
      • Baydar M.
      • et al.
      Comparison of the efficacy of transcutaneous electrical nerve stimulation, interferential currents, and shortwave diathermy in knee osteoarthritis: a double-blind, randomized, controlled, multicenter study.
      • Cheing G.L.
      • Hui-Chan C.W.
      Would the addition of TENS to exercise training produce better physical performance outcomes in people with knee osteoarthritis than either intervention alone?.
      However, participants of a previous RCT had knees with K/L grades above 2, unlike the current study. Patients with lower grades of knee OA were associated with a higher grade of efficacy of electroacupuncture treatment.
      • Qi L.
      • Tang Y.
      • You Y.
      • et al.
      Comparing the effectiveness of electroacupuncture with different grades of knee osteoarthritis: a prospective study.
      Therefore, individuals with K/L grades 0-1 may have characteristics different from those of individuals with K/L grades above 2. Moreover, TENS may be more effective for individuals with preradiographic knee OA with a lower K/L grade than for patients with knee OA with bone deformities.

      Study limitations

      This study has some limitations. First, we did not set a follow-up period with the participants after evaluation. Second, the participants were self-motivated, as they applied by obtaining information regarding this study on the website; thus, a selection bias may exist. Finally, as participants had preradiographic OA, the results cannot be applied to mild or severe OA.

      Conclusions

      Compared to sham-TENS, TENS improved the walk distance and VAS score of 6MWT in patients with preradiographic knee OA, suggesting that TENS effectively increases walk distance while reducing pain, particularly in preradiographic knee OA.

      Suppliers

      • a.
        HV-F710; Omron Healthcare Co., Ltd.
      • b.
        JMP Pro 13.0.0; SAS Institute.

      Supplemental File 1. Methods

      Inclusion and exclusion criteria

      The inclusion criteria for the study were as follows: (1) individuals aged 50 years or older
      • Wang X.-Q.
      • Huang L.-Y.
      • Liu Y.
      • Li J.-X.
      • Wu X.
      • Li H.-P.
      • et al.
      Effects of whole body vibration exercise on neuromuscular function for individuals with knee osteoarthritis: study.
      ; (2) those with K/L grades
      • Kellgren J.H.
      • Lawrence J.S.
      Radiological Assessment of Osteo-Arthrosis.
      0–1 for one or both knees, as evaluated using weight-bearing anteroposterior radiographs; and (3) those experiencing an average pain rated between 4 and 9 on a numeric rating scale (0–10 points)
      • McAlindon T.E.
      • Driban J.B.
      • Henrotin Y.
      • Hunter D.J.
      • Jiang G.L.
      • Skou S.T.
      • et al.
      OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis.
      . We included a K/L score of 0–1 in accordance with the recommendation of Osteoarthritis Research Society International (OARSI) for prevention studies
      • McAlindon T.E.
      • Driban J.B.
      • Henrotin Y.
      • Hunter D.J.
      • Jiang G.L.
      • Skou S.T.
      • et al.
      OARSI Clinical Trials Recommendations: Design, conduct, and reporting of clinical trials for knee osteoarthritis.
      . Individuals were excluded if they: (i) had symptomatic knee OA with K/L grade 2 or above, (ii) had a history of knee surgery or had received an intra-articular corticosteroid or hyaluronic acid injection within 6 months prior to enrollment
      • Bannuru R.R.
      • Natov N.S.
      • Dasi U.R.
      • Schmid C.H.
      • McAlindon T.E.
      Therapeutic trajectory following intra-articular hyaluronic acid injection in knee osteoarthritis - meta-analysis.
      , (iii) had a history of knee joint replacement or tibial osteotomy, (iv) were undergoing physical therapy, (v) had any other major joint pain (e.g., back, hip, or ankle) that could limit functional ability, (vi) had contraindications to TENS (pacemakers, dermatological conditions, and abnormal sensation in the knees), (vii) had severe medical or nervous conditions (e.g., chronic obstructive pulmonary disease, cardiovascular disease, arteriosclerosis obliterans, cerebrovascular accident, lumber disc herniation, and rheumatoid arthritis), (viii) did not utilize stairs in daily living, and (ix) were unable to walk without ambulatory assistive devices. In patients in whom both the knees were involved, the more painful knee (as identified by the participant) was evaluated.

      Sample size calculation

      Sample size was calculated based on the data provided by Chen et al.
      • Chen W.L.
      • Hsu W.C.
      • Lin Y.J.
      • Hsieh L.F.
      Comparison of intra-articular hyaluronic acid injections with transcutaneous electric nerve stimulation for the management of knee osteoarthritis: A randomized controlled trial.
      , who found a significant decrease in pain (1.14 cm on a 0–10 VAS) in patients with knee OA who underwent TENS therapy (standard deviation [SD]=1.78 cm) compared to that in patients who did not undergo TENS therapy (SD=1.97 cm). We used the G*Power program (Heinrich–Heine–Universität Düsseldorf, Düsseldorf, Germany)
      • Faul F.
      • Erdfelder E.
      • Lang A.G.
      • Buchner A.
      G* Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences.
      with a power of 80% and a significance level of 0.05, which yielded a sample size of 24 participants in each group.

      Randomization

      Participants were randomly allocated to the TENS or the sham-TENS group, using stratified and block randomization. Studies have shown that female patients have a lower sensory threshold and respond to electrical stimulation differently from male patients
      • Maffiuletti N.A.
      • Herrero A.J.
      • Jubeau M.
      • Impellizzeri F.M.
      • Bizzini M.
      Differences in electrical stimulation thresholds between men and women.
      • Aarskog R.
      • Johnson M.I.
      • Demmink J.H.
      • Lofthus A.
      • Iversen V.
      • Lopes-Martins R.
      • et al.
      Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo- controlled trial in healthy subjects.
      ; thus, the blocks were stratified by sex.
      Allocations were performed by an independent researcher who did not influence any assessments in this study. The assessors were blinded to the randomization until the outcome assessments were completed. To conceal randomization, consecutively numbered, sealed, opaque envelopes were prepared by a researcher who had no other involvement in the study. The envelopes were stored at a locked location, and then opened in sequence within each stratum to reveal the group allocation.

      Supplementary data

      References

        • Richmond J.
        • Hunter D.
        • Irrgang J.
        • et al.
        Treatment of osteoarthritis of the knee (nonarthroplasty).
        J Am Acad Orthop Surg. 2009; 17: 591-600
        • Woolf A.D.
        • Pfleger B.
        Burden of major musculoskeletal conditions.
        Bull World Health Organ. 2003; 81: 646-656
        • Jordan J.M.
        • Helmick C.G.
        • Renner J.B.
        • et al.
        Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project.
        J Rheumatol. 2007; 34: 172-180
        • Chen W.L.
        • Hsu W.C.
        • Lin Y.J.
        • Hsieh L.F.
        Comparison of intra-articular hyaluronic acid injections with transcutaneous electric nerve stimulation for the management of knee osteoarthritis: a randomized controlled trial.
        Arch Phys Med Rehabil. 2013; 94: 1482-1489
        • Cherian J.J.
        • Kapadia B.H.
        • McElroy M.J.
        • et al.
        Knee osteoarthritis: does transcutaneous electrical nerve stimulation work?.
        Orthopedics. 2016; 39: e180-e186
        • Chen L.-X.
        • Zhou Z.-R.
        • Li Y.-L.
        • et al.
        Transcutaneous electrical nerve stimulation in patients with knee osteoarthritis.
        Clin J Pain. 2016; 32: 146-154
        • Atamaz F.C.
        • Durmaz B.
        • Baydar M.
        • et al.
        Comparison of the efficacy of transcutaneous electrical nerve stimulation, interferential currents, and shortwave diathermy in knee osteoarthritis: a double-blind, randomized, controlled, multicenter study.
        Arch Phys Med Rehabil. 2012; 93: 748-756
        • Palmer S.
        • Domaille M.
        • Cramp F.
        • et al.
        Transcutaneous electrical nerve stimulation as an adjunct to education and exercise for knee osteoarthritis: a randomized controlled trial.
        Arthritis Care Res (Hoboken). 2014; 66: 387-394
        • Zeng C.
        • Li H.
        • Yang T.
        • et al.
        Electrical stimulation for pain relief in knee osteoarthritis: systematic review and network meta-analysis.
        Osteoarthritis Cartilage. 2015; 23: 189-202
        • Nakamura K.
        A “super-aged” society and the “locomotive syndrome.”.
        J Orthop Sci. 2008; 13: 1-2
      1. Japanese Orthopaedic Association. Locomotive syndrome. In: Locomotive Challenge! Council, editors. Locomotive syndrome pamphlet 2013.

        • Kellgren J.H.
        • Lawrence J.S.
        Radiological assessment of osteo-arthrosis.
        Ann Rheum Dis. 1957; 16: 494-502
        • Felson D.T.
        • Zhang Y.
        • Hannan M.T.
        • et al.
        The incidence and natural history of knee ostoathritis in the elderly. The Framingham Osteoarthritis Study.
        Arch Rheum. 1995; 38: 1500-1505
        • Tuna S.
        • Balci N.
        The relationship between radiological severity and functional status in patients with knee osteoarthritis.
        Clin Rheumatol. 2014; 33: 667-670
        • Ruhdorfer A.
        • Wirth W.
        • Hitzl W.
        • Nevitt M.
        • Eckstein F.
        Association of thigh muscle strength with knee symptoms and radiographic disease stage of osteoarthritis: data from the osteoarthritis initiative.
        Arthritis Care Res (Hoboken). 2014; 66: 1344-1353
        • Guermazi A.
        • Niu J.
        • Hayashi D.
        • et al.
        Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).
        BMJ. 2012; 345e5339
        • Hart D.J.
        • Spector T.D.
        Kellgren & Lawrence grade 1 osteophytes in the knee--doubtful or definite?.
        Osteoarthritis Cartilage. 2003; 11: 149-150
        • Cibere J.
        • Sayre E.C.
        • Guermazi A.
        • et al.
        Natural history of cartilage damage and osteoarthritis progression on magnetic resonance imaging in a population-based cohort with knee pain.
        Osteoarthritis Cartilage. 2011; 19: 683-688
        • Bruyere O.
        • Cooper C.
        • Arden N.
        • et al.
        Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.
        Drugs Aging. 2015; 32: 179-187
        • Dobson F.
        • Hinman R.S.
        • Roos E.M.
        • et al.
        OARSI recommended performance-based tests to assess physical function in people diagnosed with hip or knee osteoarthritis.
        Osteoarthritis Cartilage. 2013; 21: 1042-1052
        • Iijima H.
        • Fukutani N.
        • Aoyama T.
        • et al.
        Clinical impact of coexisting patellofemoral osteoarthritis in Japanese patients with medial knee osteoarthritis.
        Arthritis Care Res (Hoboken). 2016; 68: 493-501
        • Dobson F.
        • Hinman R.S.
        • Hall M.
        • et al.
        Reliability and measurement error of the Osteoarthritis Research Society International (OARSI) recommended performance-based tests of physical function in people with hip and knee osteoarthritis.
        Osteoarthritis Cartilage. 2017; 25: 1792-1796
        • Wang C.Y.
        • Olson S.L.
        • Protas E.J.
        Test-retest strength reliability: hand-held dynamometry in community-dwelling elderly fallers.
        Arch Phys Med Rehabil. 2002; 83: 811-815
        • Katz J.
        • Melzack R.
        Measurement of pain.
        Surg Clin North Am. 1999; 79: 231-252
        • Naylor J.M.
        • Hayen A.
        • Davidson E.
        • et al.
        Minimal detectable change for mobility and patient-reported tools in people with osteoarthritis awaiting arthroplasty.
        BMC Musculoskelet Disord. 2014; 15: 235
        • Akai M.
        • Doi T.
        • Fujino K.
        • Iwaya T.
        • Kurosawa H.
        • Nasu T.
        An outcome measure for Japanese people with knee osteoarthritis.
        J Rheumatol. 2005; 32: 1524-1532
        • Tokuda M.
        • Tabira K.
        • Masuda T.
        • Nishiwada T.
        • Shomoto K.
        Effect of modulated-frequency and modulated-intensity transcutaneous electrical nerve stimulation after abdominal surgery: a randomized controlled trial.
        Clin J Pain. 2014; 30: 565-570
        • Aarskog R.
        • Johnson M.I.
        • Demmink J.H.
        • et al.
        Is mechanical pain threshold after transcutaneous electrical nerve stimulation (TENS) increased locally and unilaterally? A randomized placebo-controlled trial in healthy subjects.
        Physiother Res Int. 2007; 12: 251-263
        • Melzack R.
        • Wall P.D.
        Pain mechanisms: a new theory.
        Science. 1965; 150: 971-979
        • Sluka K.A.
        • Walsh D.
        Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness.
        J Pain. 2003; 4: 109-121
        • Chimenti R.L.
        • Frey-Law L.A.
        • Sluka K.A.
        A mechanism-based approach to physical therapist management of pain.
        Phys Ther. 2018; 98: 302-314
        • French H.P.
        • Fitzpatrick M.
        • Fitzgerald O.
        Responsiveness of physical function outcomes following physiotherapy intervention for osteoarthritis of the knee: an outcome comparison study.
        Physiotherapy. 2011; 97: 302-308
        • Wang P.
        • Yang L.
        • Liu C.
        • et al.
        Effects of whole body vibration exercise associated with quadriceps resistance exercise on functioning and quality of life in patients with knee osteoarthritis: a randomized controlled trial.
        Clin Rehabil. 2016; 30: 1074-1087
        • Kelly A.M.
        The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain.
        Emerg Med J. 2001; 18: 205-207
        • Hensor E.M.
        • Dube B.
        • Kingsbury S.R.
        • Tennant A.
        • Conaghan P.G.
        Toward a clinical definition of early osteoarthritis: onset of patient-reported knee pain begins on stairs. Data from the osteoarthritis initiative.
        Arthritis Care Res (Hoboken). 2015; 67: 40-47
        • Cheing G.L.
        • Hui-Chan C.W.
        Would the addition of TENS to exercise training produce better physical performance outcomes in people with knee osteoarthritis than either intervention alone?.
        Clin Rehabil. 2004; 18: 487-497
        • McAlindon T.E.
        • Bannuru R.R.
        • Sullivan M.C.
        • et al.
        OARSI guidelines for the non-surgical management of knee osteoarthritis.
        Osteoarthritis Cartilage. 2014; 22: 363-388
        • Qi L.
        • Tang Y.
        • You Y.
        • et al.
        Comparing the effectiveness of electroacupuncture with different grades of knee osteoarthritis: a prospective study.
        Cell Physiol Biochem. 2016; 39: 2331-2340